Methotrexate sodium loaded Tween 80 stabilised gold nanoparticles: synthesis and characterisation
by Ankita U. Patel; Girish K. Jani; Ketan Ranch; Akshay Koli; Naresh B. Dharmani
International Journal of Nanoparticles (IJNP), Vol. 11, No. 1, 2019

Abstract: Cancer is a disease characterised by uncontrolled multiplication and spread of abnormal forms of the body's own cells. Methotrexate sodium is an antineoplastic agent of the anti-metabolite class of chemotherapy drugs, which inhibits dihydrofolate reductase and blocking the conversion of dihydrofolic acid to tetrahydrofolic acid. Metal nanoparticles such as gold nanoparticles are having a smaller size, more stable and relatively narrow size distribution which provide opportunities for effective active or passive targeted delivery. Thus, the gold nanoparticles were synthesised using a chemical reduction method, involving the reduction of chloroauric acid by trisodium citrate, stabilised by Tween 80 and Methotrexate sodium was loaded on to it. Physical observations and FTIR analysis showed that drug and excipients pass the drug-excipient compatibility study. The present work reports a significant and a simple, process capable of synthesising size-controlled Tween 80 stabilised gold nanoparticles rapidly under ambient conditions.

Online publication date: Fri, 22-Feb-2019

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanoparticles (IJNP):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com